Sprott Physical Silver Trust (PSLV) is a closed-end trust offering fully allocated physical silver stored at the Royal Canadian Mint, with physical redemption available to large unitholders, while iShares Silver Trust (SLV) is a grantor trust holding physical silver in London vaults without retail redemption rights. Both ETFs provide direct exposure to silver bullion prices with no equity holdings or sector allocations beyond the precious metals commodity.

ASTS is trading up +4.92% to $53.48 during regular market hours, rebounding from Friday's -10.5% close of $50.97. Primary catalyst: Deutsche Bank upgraded ASTS to Buy from Hold with a $93 target, calling Friday's SpaceX-driven selloff a market misread.

VEEA is trading down -21.93% (near $4.45) during the regular session Monday, sharply reversing after Friday's +47.29% surge to a $5.70 close. The decline reflects profit-taking and mean reversion rather than fresh negative news, following Friday's parabolic run on restored Nasdaq listing compliance, NovaGen merger speculation, and the TROLLEE rollout.

CD is trading down -20.67% intraday Monday, around $6.87 versus Friday's $8.66 close, during regular Nasdaq session hours. The drop extends extreme volatility rather than a single fresh catalyst: the low-float micro-cap fell -20.6% Friday after a parabolic run from ~$3.50 in mid-September to an intraday high above $12 on Oct. 8.

CTNM is down -27.50% to about $9.70, erasing a +27% premarket surge that briefly lifted shares to roughly $16.99 following the Bristol Myers Squibb (BMS) readout. The reversal unfolded during Monday's session after BMS's Phase 3 ALOFT-IPF trial of admilparant revealed its 60 mg dose met the primary endpoint but the 120 mg dose missed statistical significance, raising dose-response doubts.

The $1.00 price objective examined here is a fallback target drawn from public discussion, not an analyst consensus, because FRGT lacks credible, current analyst coverage. The latest verified closing price is $0.2940 (October 9, 2026), meaning the stock would need to rise roughly 240% to reach $1.00 — a very large move.

MEDS (DataMeds AI) surged nearly +200% in today's session after news of a new deal with Axe Compute (AGPU). Primary catalyst: an agreement with Axe Compute, a neocloud AI infrastructure platform, expanding DataMEDS' AI-driven healthcare and data strategy.

WFF is up +92.03% during Monday's regular session, trading near $23.60 versus Friday's close of $12.29. The move extends Friday's +499.51% blow-off, when the low-float Nasdaq micro-cap gapped from roughly $2.05 to a $12.29 close on ~79M shares.

Tokenization is the central growth catalyst: Management is pivoting the platform toward blockchain-enabled digital securities and real-world asset tokenization, with an initial issuer engagement (PureWave Hydrogen) serving as a potential blueprint. Regulatory resolution is the single largest swing factor: An active U.S. Securities and Exchange Commission (SEC) enforcement matter and multiple Nasdaq non-compliance notices create an unresolved overhang that could define the company's near-term trajectory.

Different layers of the chip supply chain: ASML sells capital equipment, while ENTG supplies recurring consumables and materials. Scale gap is substantial: ASML's market value is roughly 30 times larger than Entegris', reflecting very different business models and growth profiles.

IONQ is trading down -8.80% to about $36.38 during Monday's regular session, versus Friday's close of $39.89, extending an early premarket decline of roughly -2% to -3%. The primary catalyst is IonQ's agreement to acquire cybersecurity firm Elisity in an all-stock deal valued at up to $1.3 billion, including up to $150 million in performance-based earnouts.

Freight Technologies (FRGT) is up roughly +31% intraday Monday, trading near $0.38 after closing Friday around $0.29. The gain is occurring during regular market hours, with the stock spiking as much as about +35% to roughly $0.40 early in the session.

The $2.00 objective is not an analyst-derived target: Netcapital Inc. (NCPL) has no meaningful sell-side price-target coverage, so the figure reflects a technical milestone drawn from public discussion rather than a consensus. With the stock recently quoted near $1.14, reaching $2.00 would require a roughly 75% advance, a very large move even for this exceptionally volatile micro-cap.

Rebranding inflection point: The July 2026 transition from Wellgistics Health (WGRX) to DataMEDS AI (MEDS) reframes the company as a Health IT and health-data monetization play rather than a traditional pharmaceutical distributor. Product-led catalysts ahead: The expansion of the EinsteinRx™ AI platform and PharmacyChain™ blockchain infrastructure into medical, laboratory, and wearables data is the central strategic storyline to watch.

Major upcoming catalyst: The completion of a restructuring that shifts Freight Technologies away from low-margin freight brokerage toward a software and AI-driven logistics technology model, expected to be finalized by the end of the third quarter of 2026. Strategic positioning: The company is consolidating around its Transportation Management System (TMS, software that helps shippers, carriers, and brokers plan and execute freight moves), Fleet Rocket, and related visibility and AI tools in the high-volume U.S.–Mexico corridor.

NCPL surged +37.72% to about $1.57, versus a prior-session close of $1.14, with the move led in premarket trading. The gain appears driven by speculative momentum in a low-float microcap, not a company-specific fundamental catalyst.

ASML is the sole global supplier of extreme ultraviolet (EUV) lithography systems, giving it a near-monopoly position at the center of AI chip production, while Nova is a smaller, faster-growing provider of semiconductor metrology (measurement) and process-control tools. Both stocks have posted strong year-to-date gains on AI-driven demand, though NVMI has experienced a sharper recent pullback relative to ASML .

NIVF is up +257.14% to about $0.25 versus the prior session, but the move is mechanical rather than a genuine rally. A 1-for-4 reverse stock split took effect today, quadrupling the share price while cutting shares outstanding from ~35.7M to ~8.9M.

Ondas Holdings ( ONDS ) is a high-growth, defense-focused autonomy and robotics company whose stock has staged an explosive rally, while Palantir Technologies ( PLTR ) is a much larger, already-profitable AI software leader. ONDS is scaling rapidly off a small base, with revenue growing several-fold, while PLTR generates roughly $1.8 billion or more in quarterly revenue with strong margins.

SECZ is down roughly -11.1% during regular trading, sliding to about $12.28 from Friday's close of $13.82. The decline occurred in the NYSE market session, unwinding part of last week's sharp rally (+9.2% on Oct. 9 and +11.1% on Oct. 8).